Related Experiment Video
Updated: Dec 16, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Long non-coding RNAs and MYC association in hematological malignancies
Leonidas Benetatos1, Agapi Benetatou2, Georgios Vartholomatos3
1Blood Bank, Preveza General Hospital, 48100, Preveza, Greece. benetatosleon@yahoo.com.
Long non-coding RNAs (lncRNAs) regulate blood cell development and are implicated in blood cancers. Their interaction with MYC drives malignancy by promoting proliferation and treatment resistance.
Area of Science:
- Molecular Biology
- Hematology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are key regulators of gene expression with critical roles in cell biology.
- lncRNAs play a significant role in hematopoiesis, influencing stem cell renewal and progenitor differentiation.
- The transcription factor MYC is a master regulator involved in both normal hematopoiesis and malignancies.
Purpose of the Study:
- To review the intricate crosstalk between lncRNAs and MYC in the context of hematopoiesis.
- To elucidate the pathogenetic mechanisms by which lncRNA-MYC interactions contribute to hematologic malignancies.
- To highlight recent findings on the role of lncRNAs in myeloid and lymphoid cancers.
Main Methods:
- Literature review of recent findings on lncRNA and MYC interactions.
- Analysis of the role of lncRNAs in regulating hematopoietic stem cells and progenitor differentiation.
- Examination of the impact of lncRNA-MYC axis on cancer hallmarks like apoptosis, proliferation, and metabolism.
Main Results:
- lncRNAs exhibit lineage-restricted expression patterns during hematopoiesis, distinct from coding mRNAs.
- MYC regulates lncRNA expression, and conversely, lncRNAs modulate MYC activity.
- The aberrant interaction between MYC and lncRNAs is a common feature in myeloid and lymphoid malignancies, promoting cancer progression.
Conclusions:
- The crosstalk between lncRNAs and MYC is a critical factor in the pathogenesis of acute and chronic hematologic malignancies.
- Dysregulation of this axis contributes to key cancer hallmarks, including enhanced proliferation, metabolic alterations, and treatment resistance.
- Targeting the lncRNA-MYC interaction may offer novel therapeutic strategies for hematologic cancers.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells

